Search Results - "Matera, M.G"

Effects of chronic administration of β-blockers on airway responsiveness in a murine model of heart failure by Rinaldi, B, Capuano, A, Gritti, G, Donniacuo, M, Scotto Di Vettimo, A, Sodano, L, Rafaniello, C, Rossi, F, Matera, M.G

“…Abstract Lung function abnormalities, both at rest and during exercise, are frequently observed in patients with chronic heart failure (HF), also in absence of…”
Get full text

The functional impact of adding salmeterol and tiotropium in patients with stable COPD by Cazzola, M., Centanni, S., Santus, P., Verga, M., Mondoni, M., di Marco, F., Matera, M.G.

“…The aim of this double-blind, double-dummy, crossover, randomised, pilot study was to explore the acute effects of adding salmeterol and tiotropium in patients…”
Get full text

LABAs in asthmatic children: Highlights and new inside by Miraglia del Giudice, M, Matera, M.G, Capristo, C, Conte, M, Santaniello, F, Chinellato, I, Leonardi, S, Miraglia del Giudice, M.C, Perrone, L

“…Abstract International asthma guidelines recommend increasing the dose of ICS or adding leukotriene modifiers or the use of long-acting inhaled beta2-agonists…”
Get full text

Comparison of the acute effect of tiotropium versus a combination therapy with single inhaler budesonide/formoterol on the degree of resting pulmonary hyperinflation by Santus, P., Centanni, S., Verga, M., Di Marco, F., Matera, M.G., Cazzola, M.

“…In 20 COPD patients ( FEV 1 ⩽ 65 % predicted, IC < 80 % predicted), we evaluated changes in the degree of pulmonary hyperinflation after acute administration…”
Get full text

Effects of neuraminidase on equine isolated bronchi by Matera, M.G, Calzetta, L, Sanduzzi, A, Page, C.P, Cazzola, M

“…Abstract It has been demonstrated in mammals that the airway hyper-responsiveness, which accompanies viral infections, is the result of increased reflex…”
Get full text

Effect of formoterol/budesonide combination on arterial blood gases in patients with acute exacerbation of COPD by Cazzola, M., Noschese, P., De Michele, F., D’Amato, G., Matera, M.G.

“…Patients with severe chronic airway obstruction might suffer dangerous hypoxemia after administration of a β-agonist despite bronchodilation. We first compared…”
Get full text

Salmeterol and formoterol in partially reversible severe chronic obstructive pulmonary disease: a dose-response study by Cazzola, M, Matera, M G, Santangelo, G, Vinciguerra, A, Rossi, F, D'Amato, G

“…When testing the response to beta 2-agonist drugs in severe chronic obstructive pulmonary disease (COPD), a dose-response assessment should be undertaken. This…”
Get more information

A single high dose of formoterol is as effective as the same dose administered in a cumulative manner in patients with acute exacerbation of COPD by CAZZOLA, M., SANTUS, P., MATERA, M.G., CARLUCCI, P., BELLOLI, E., DI MARCO, F., CENTANNI, S.

“…Several clinical trials have shown that the inhaled β 2-agonists with long-acting properties, formoterol and salmeterol, may be effective in acute…”
Get full text

Bronchodilator effect of an inhaled combination therapy with salmeterol + fluticasone and formoterol + budesonide in patients with COPD by CAZZOLA, M., SANTUS, P, DI MARCO, F., BOVERI, B., CASTAGNA, F., CARLUCCI, P., MATERA, M.G., CENTANNI, S.

“…In the present trial, we compared the broncholytic efficacy of the combination therapy with 50 μg salmeterol + 250 μg fluticasone and 12 μg formoterol + 400 μg…”
Get full text

Influence of higher than conventional doses of oxitropium bromide on formoterol-induced bronchodilation in COPD by Cazzola, M., Matera, M.G., Di Perna, F., Califano, C., D'Amato, M., Mazzarella, G.

“…We examined the influence of higher than conventional doses of oxitropium bromide on formoterol-induced bronchodilation in patients with partially reversible…”
Get full text

The anti-proliferative effects of adiponectin on human lung adenocarcinoma A549 cells and oxidative stress involvement by Nigro, E, Stiuso, P, Matera, M G, Monaco, M L, Caraglia, M, Maniscalco, M, Perrotta, F, Mazzarella, G, Daniele, A, Bianco, A

“…Adiponectin (Acrp30) plays an important role in energy metabolism and inflammation. Recently, in vivo serum Acrp30 levels have been reported to be correlated…”
Get full text

Prolonged-release pirfenidone in patients with pulmonary fibrosis as a phenotype of post-acute sequelae of COVID-19 pneumonia. Safety and efficacy by Sansores, R.H., Ramírez-Venegas, A., Montiel-Lopez, F., Domínguez-Arellano, S., Alva-Lopez, L.F., Falfán-Valencia, R., Pérez-Rubio, G., Olaya-López, E., Zavaleta-Martínez, E.O., Aguilar-Medina, S., Escobar-Alvarado, J.C., Poo, J.L., Matera, M.G., Cazzola, M.

“…One of the major concerns with post-acute sequelae of COVID-19 (PASC) is the development of pulmonary fibrosis, for which no approved pharmacological treatment…”
Get full text

Clinical effect of corticosteroids in asthma‐affected horses: A quantitative synthesis by Calzetta, L., Rogliani, P., Page, C., Roncada, P., Pistocchini, E., Soggiu, A., Piras, C., Urbani, A., Matera, M.G.

“…Summary Background There are limited findings from low‐powered studies based on few number of subjects with equine asthma. Furthermore, no studies have been…”
Get full text

The Protective Role of Epithelium-derived Nitric Oxide in Isolated Bovine Trachea by Spicuzza, L., Basile, L., Belvisi, M.G., Bellofiore, S., Matera, M.G., Cazzola, M., Di Maria, G.U.

“…Airway epithelial cells from bovine airways can release relaxant factors such as nitric oxide (NO) and prostaglandin E2 and the removal of airway epithelium…”
Get full text

Anxiety/depression and impaired asthma control in adolescents. Is an increased basal cholinergic tone a possible link ? by Liccardi, G, Calzetta, L, Milanese, M, Bilò, M B, Liccardi, M V, Matera, M G, Baiardini, I, Rogliani, P

Get full text

Olodaterol hydrochloride by Cazzola, M., Matera, M.G.

Get full text

Olodaterol hydrochloride by Cazzola, M., Matera, M.G.

Get full text

Association of β 2-adrenergic agonists and tiotropium:is the combination justified? by Cazzola, M., Matera, M.G., O’Donnell, K.M.

Get full text

Should long-acting β2-agonists be considered an alternative first choice option for the treatment of stable COPD? by Cazzola, M., Matera, M.G.

Get full text

Onset of action of formoterol/budesonide in single inhaler vs. formoterol in patients with COPD by Cazzola, M., Santus, P., Di Marco, F., Carlucci, P., Mondoni, M., Matera, M.G., Centanni, S.

“…Formoterol is a β 2-agonist bronchodilator that combines a fast onset of action with a long duration of broncholytic effect. An increasing documentation is…”
Get full text